Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Depreciation and Depletion (2022 - 2024)

Historic Depreciation and Depletion for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Q4 2024 value amounting to $48000.0.

  • Centessa Pharmaceuticals' Depreciation and Depletion fell 4782.61% to $48000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $300000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $300000.0 for FY2024, which is 0.0% changed from last year.
  • Per Centessa Pharmaceuticals' latest filing, its Depreciation and Depletion stood at $48000.0 for Q4 2024, which was down 4782.61% from $82000.0 recorded in Q3 2024.
  • Centessa Pharmaceuticals' 5-year Depreciation and Depletion high stood at $92000.0 for Q4 2023, and its period low was $28000.0 during Q1 2022.
  • Its 3-year average for Depreciation and Depletion is $60916.7, with a median of $65000.0 in 2024.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first soared by 16250.0% in 2023, then crashed by 4782.61% in 2024.
  • Quarter analysis of 3 years shows Centessa Pharmaceuticals' Depreciation and Depletion stood at $36000.0 in 2022, then soared by 155.56% to $92000.0 in 2023, then crashed by 47.83% to $48000.0 in 2024.
  • Its Depreciation and Depletion stands at $48000.0 for Q4 2024, versus $82000.0 for Q3 2024 and $84000.0 for Q2 2024.